Group 1 - AGNC Investment Corp. is identified as a top cheap stock under $20, with Piper Sandler raising the price target to $11 from $10.50 while maintaining an Overweight rating ahead of fiscal Q4 results [1] - The mortgage finance sector is experiencing a positive shift, driven by a decrease in 30-year mortgage rates from over 7% to 6.2% and tightening agency spreads [1] - Keefe Bruyette also raised AGNC's price target to $11 from $10.50, maintaining an Outperform rating, indicating a constructive outlook for agency MBS REITs heading into the new year [3] Group 2 - The market for mortgage applications is showing growth, with an 18% sequential increase and over 100% year-over-year surge in refinance activity, although normalization is still in progress [2] - AGNC operates as a real estate investment trust, focusing on residential mortgage pass-through securities and collateralized mortgage obligations, with government guarantees on principal and interest payments [4]

Core Viewpoint - Rithm Capital Corp. (NYSE:RITM) is identified as a promising investment opportunity, particularly after its recent acquisition of Paramount Group, Inc., which enhances its asset management capabilities and commercial real estate presence [2][3]. Group 1: Acquisition Details - Rithm Capital Corp. successfully completed the acquisition of Paramount Group, Inc. on December 19, which includes 13 owned and 4 managed office assets totaling over 13.1 million square feet [2]. - The acquisition is expected to significantly bolster Rithm's fully integrated and diversified asset management platform, allowing for further development of the portfolio [3]. - Paramount Group will be integrated into Rithm's platform and rebranded to capitalize on new opportunities across the portfolio [4]. Group 2: Company Operations - Rithm Capital Corp. operates in various segments, including Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate [5]. Group 3: Analyst Ratings - Piper Sandler analyst Crispin Love has reaffirmed a bullish stance on Rithm Capital Corp., assigning a Buy rating with a price target of $15.50 [1].

If you cannot participate in the live mode, a replay will be available for one week following the date of the live conference call. To access the replay, please dial 1-866-813-9403 followed by the access code: 959096. About RioCan RioCan meets the everyday shopping needs of Canadians through the ownership, management and development of necessity-based and mixed-use properties in densely populated communities. As at September 30, 2025, our portfolio is comprised of 173 properties with an aggregate net leasab ...

Core Viewpoint - U.S. stock futures are showing positive movement, particularly with Nasdaq 100 futures increasing by approximately 1% on Friday, while Outlook Therapeutics Inc faces significant stock decline due to FDA's response on its biologics license application [1]. Company Specifics - Outlook Therapeutics Inc (NASDAQ:OTLK) experienced a sharp decline of 60.9%, dropping to $0.62 in pre-market trading after the FDA issued a complete response letter regarding its ONS-5010/LYTENAVA application for treating wet age-related macular degeneration, indicating that the application cannot be approved in its current form [2][1]. - Intelligent Bio Solutions Inc (NASDAQ:INBS) saw a decrease of 19.2%, falling to $7.70 in pre-market trading following the announcement of a $10 million private placement priced at-the-market under Nasdaq rules [3]. - Net Lease Office Properties (NYSE:NLOP) shares dipped by 8.9% to $23.50 in pre-market trading [3]. - Progressive Corp (NYSE:PGR) tumbled by 5.8% to $214.60 in pre-market trading [3]. - Old Republic International Corp (NYSE:ORI) slipped by 4.8% to $43.42 in pre-market trading [3]. - Cango Inc – ADR (NYSE:CANG) fell by 4% to $1.44 in pre-market trading [3]. - Xeris Biopharma Holdings Inc (NASDAQ:XERS) decreased by 3.6% to $7.57 in pre-market trading after a previous gain of over 7% on Wednesday [3]. - Biohaven Ltd (NYSE:BHVN) fell by 2.6% to $11.00 in pre-market trading [3]. - RealReal Inc (NASDAQ:REAL) slipped by 2.3% to $15.41 in pre-market trading [3].

Core Viewpoint - Global Net Lease, Inc. has declared a dividend of $0.190 per share of common stock, payable on January 16, 2026, to stockholders of record as of January 12, 2026 [1] Group 1: Dividend Information - The dividend is authorized by the Company's board of directors and is paid quarterly in arrears during the first month following the end of each fiscal quarter [2] Group 2: Company Overview - Global Net Lease, Inc. is a publicly traded internally managed real estate investment trust that focuses on acquiring and managing a global portfolio of income-producing net lease assets across the U.S., and Western and Northern Europe [3]

Group 1 - Great Portland Estates is a London-based real estate investment trust (REIT) specializing in the acquisition, development, and management of commercial properties in central London, focusing on office space, retail premises, and mixed-use residential schemes in prime locations [3][4] - The company's investment strategy is centered on identifying underutilized or outdated properties and unlocking value through strategic redevelopment [4] - Great Portland Estates has a fifty-day moving average of $4.42 and a 200-day moving average of $4.49, indicating its recent price performance [2][3] Group 2 - Recent analyst ratings show that BNP Paribas upgraded Great Portland Estates from a "hold" to an "outperform" rating, while Goldman Sachs downgraded it from a "buy" to a "hold" rating, resulting in a consensus rating of "Moderate Buy" [1] - The stock price of Great Portland Estates opened at $4.4620 after previously closing at $4.2850, with a trading volume of 202 shares [6]

Core Viewpoint - Innovative Industrial Properties (IIPR) has experienced significant volatility recently, with a notably high dividend yield attracting attention as a potential investment opportunity [1]. Group 1: Company Overview - IIPR is characterized by its high dividend yield, which may entice investors who are not closely monitoring the stock [1]. - The company operates in a sector with long growth runways, indicating potential for future appreciation [1]. Group 2: Analyst Insights - Julian Lin, a financial analyst, focuses on identifying undervalued companies with secular growth, emphasizing strong balance sheets and management teams [1]. - Lin leads an investing group that shares high-conviction stock picks aimed at delivering significant alpha compared to the S&P 500 [1].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3]. Group 2: Company Performance and Stock Impact - Alexandria Real Estate, a real estate investment trust focused on life science industries, reported lower occupancy rates and slower leasing activity, leading to a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property [4][5]. - On October 27, 2025, the company announced disappointing results for Q3 2025 and reduced guidance for the fiscal year, causing its stock price to drop by $14.93 per share, or over 19%, from $77.87 to $62.94 [6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the case in the U.S. District Court for the Central District of California, under the case caption Hern v. Alexandria Real Estate Equities, Inc., et al. [3].

Group 1: Alexander's (ALX) - The company is a real estate investment trust engaged in leasing, managing, developing, and redeveloping properties [1] - The Zacks Consensus Estimate for its current year earnings has increased by 7% over the last 60 days [1] - The company has a dividend yield of 8.2%, significantly higher than the industry average of 4.8% [1] Group 2: Kforce (KFRC) - Kforce provides professional staffing services and solutions to clients on both temporary and permanent bases [2] - The Zacks Consensus Estimate for its current year earnings has increased by 3.4% over the last 60 days [2] - The company has a dividend yield of 4.9%, compared to the industry average of 2.3% [2] Group 3: BHP Group Limited (BHP) - BHP is one of the world's largest mining companies with operations in multiple countries including Australia, Brazil, Canada, Chile, Peru, and the United States [3] - The Zacks Consensus Estimate for its current year earnings has increased by 13% over the last 60 days [3] - The company has a dividend yield of 3.9%, while the industry average is 0.0% [3]